|
|
||||||||
a Bioengineering Unit, Wolfson Building, University of Strathclyde, 106 Rottenrow, Glasgow, G4 ONW Scotland
b University of North Texas Health Sciences Centre, 2400 Camp Bowie Blvd, Fort Worth, Texas 76107
c University of Kirikkale, Angora Evleri G-8, Bl. No:1, Beysukent Ankara, 06800 Turkey
(Email: terrance.gourlay@strath.ac.uk; ao-yurvati@hsc.unt.edu; sgunaydin@isnet.net.tr).
| The first 20% of the full text of this article appears below. |
To the Editor:
We write in reference to the recent joint clinical practice guidelines and recommendations of The Society of Thoracic Surgeons (STS) and Society of Cardiovascular Anesthesiologists for perioperative blood transfusion and blood conservation in cardiac surgery [1].
Although we applaud the efforts to provide clear guidance and recommendations for blood conservation, we disagree with the committees position on leukocyte filtration, and we are particularly concerned by the notion that there is a lack of clinical evidence to support the use of leukocyte filtration. The effect of leukocyte filtration on blood product usage has not been extensively studied, but there is evidence from at least one focused clinical study that demonstrates just such a benefit [2], and there is
Related Article
Ann. Thorac. Surg. 2008 85: 1139.
This article has been cited by other articles:
![]() |
V. A. Ferraris Reply Ann. Thorac. Surg., March 1, 2008; 85(3): 1139 - 1139. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |